Acetylcholinesterase (AChE) is expressed as several homomeric and heterooligomeric forms in a wide variety of tissues such as neurons in the central and peripheral nervous systems and their targets including skeletal muscle, endocrine and exocrine glands. In addition, glycolipid-anchored forms are expressed in erythropoietic and lymphopoietic cells. While transcriptional and post-transcriptional regulation is important for determining which AChE oligomeric forms are expressed in a given tissue, translational and post-translational regulatory mechanisms at the level of protein folding, assembly and sorting play equally important roles in assuring that the AChE molecules reach their intended sites on the cell surface in the appropriate numbers. This brief review will focus on the latter events in the cell with the goal of providing novel therapeutic interventional strategies for the treatment of organophosphate and carbamate pesticide and nerve agent exposure.
In all vertebrates, acetylcholinesterase (AChE) is encoded by a single gene that gives rise to three alternative transcripts. The molecular basis for the alternative splicing variants of the single AChE gene have been described and reviewed extensively (see Massoulie et al. 1993; Taylor and Radi c 1994; Legay 2000; Rotundo 2003 ; for reviews) and will not be reviewed in great detail here. Suffice it to say that the AChE gene in vertebrates encodes three alternative splicing variants sharing 95% of their coding sequence but differing in their carboxyl termini which allows them to assemble with the noncatalytic subunits (collagen tail or PRiMA associated alternative AChE variant), to be anchored to the plasma membrane via a glycolipid anchor (hydrophobic glycophosphoinositol lipid anchor-linked alternative AChE variant) or be secreted as a monomeric form in some species-specific and special cases (monomeric readthrough alternative AChE variant). The primary sequence of AChE deduced from from its cDNA was published in 1986 by Schumacher et al., and its three dimensional structure published five years later by Sussman et al. in 1991 . The two non-catalytic subunits are the collagenlike tail (ColQ) (Krejci et al. 1997) which anchors the catalytic subunits to the synaptic basal lamina at the neuromuscular junction, and the transmembrane protein proline rich membrane anchor (PRiMA) (Perrier et al. 2002) which anchors the enzyme at cholinergic synapses in the central and peripheral nervous systems. It is highly likely that a similar set of processing steps occurs for the biogenesis of butyrylcholinesterase (BuChE), a serum protein which is produced mainly in the liver but also at lower levels in many electrically excitable cells (reviewed in Chatonnet and Lockridge 1989) .
All AChE forms are exportable glycoproteins, secreted and membrane-bound, and as such undergo similar processing in the secretory pathway. They are synthesized on the rough endoplasmic reticulum (RER) where they undergo co-translational glycosylation (Rotundo 1988) which adds three to four asparagine-linked oligosaccharides to the elongating polypeptide chain. They then undergo a lengthy process of folding, assembly and quality control before exiting the RER and translocating to the Golgi apparatus for further processing, and, in the case of the collagen-tailed form, possible assembly with the non-catalytic subunits (Rotundo 1984a,b) . The addition of the PRiMA subunit has been inferred to occur in the RER based on the sensitivity of the PRiMA-linked G4 AChE to endoglycosidase-H (Chen et al. 2011) . Following processing, the oligomeric AChE forms are packaged in the trans-Golgi apparatus into tubulovesicular organelles for transport to the appropriate cell surface domain.
Because of the ease with which AChE can be detected by colorimetric and radiometric enzymatic assays, histochemical localization at the light and electron microscopic levels using colorimetric or electron dense precipitates, and a variety of immunocytochemical and fluorescent toxin labeling techniques, an enormous literature on the subcellular localization of AChE and BuChE exists. Following the discovery of the family of AChE oligomeric forms by Jean Massouli e and his group in the late 1960s and the elucidation of the structural basis for these forms in several labs (Massouli e and Rieger 1969; Rosenberry et al. 1972; Rosenberry and Richardson 1977; Anglister and Silman 1978; Lee et al. 1982a,b) as well as the importance of specific subunits (Cartaud et al., 1991) like the collagen-like tail for its localization and concentration at the neuromuscular synapse (Hall 1973; Lwebuga-Mukasa et al. 1976; McMahan et al. 1978; Rotundo et al. 1997) or the circa 120 amino acid transmembrane anchor protein PRiMA (Perrier et al. 2002) renewed interest on the assembly and targeting of these forms ensued. The major events in the biogenesis, transport, processing and localization of AChE are summarized in Fig. 1 .
Early events in the biogenesis of AChE
The AChE transcripts are not only randomly distributed throughout the cells that express them but also rather appear to be highly localized around the nuclei (Tsim et al. 1992; Jasmin et al. 1993; Rossi et al. 2000) , tightly associated with the RER where at least in muscle they are anchored via an RNA-binding protein called Pumilio2 (Marrero et al. 2011) . This most likely serves to insure translational specifically in the regions of interest. In neurons, it might also serve as a mechanism for transporting the AChE transcript to other locations in the cell for local translation. All AChE polypeptides are translated on the rough endoplasmic reticulum and are co-translationally glycosylated (Rotundo 1984a (Rotundo ,b, 1988 . However, not all newly translated polypeptide chains correctly fold and assemble into catalytically active enzyme molecules. Depending on the cell type, about 20% or fewer of the molecules correctly fold, maintain catalytic activity and go on the exit the RER, and continue to have their asparagine-linked oligosaccharides processed in the Golgi apparatus (Rotundo, 1984) . The vast majority are rapidly degraded by the endoplasmic reticulum associated degradation system. The remaining active enzyme consists primarily of assembled forms including dimers and tetramers; however, the abundance of each type depends in large part on the cell type. Some tissue cultured cells even secrete monomeric AChE although it is not clear what its structure is and whether its carboxyl terminus has been trimmed by proteases. In primary cells, most of the exported enzyme is the stabilized tetramer which goes on to have its oligosaccharides processed to endoglycosidase-H resistant oligomers in the Golgi apparatus. As for the inactive AChE molecules, only a few studies have been conducted to demonstrate their existence; however, they are clearly present in vivo as well as in tissue cultured cells (Chatel et al. 1993a,b; Campanari et al. 2014) and there is now clear evidence that the AChE molecules in this pool can at least in part be rescued and rerouted to the cell surface in culture and to the synapses in vivo (Ruiz et al. 2015 , and unpublished observations).
Kinetics of AChE synthesis, transport and secretion
The biogenesis, transport and processing of AChE has been studied in several laboratories using tissue cultured skeletal muscle or cell lines (Wilson and Walker 1974; Rotundo and Fambrough 1980; Lazar et al. 1984 ) using recovery from diisopropylfluorophosphate or dense amino acid shifting techniques. Interestingly, the transport time through the secretory pathway is very similar across cell types requiring about 3 h from time of synthesis to secretion at the plasma membrane. This transport time includes transit through the Golgi apparatus and all the intracellular processing events including processing of the asparagine-linked oligosaccharides and assembly with other catalytic and non-catalytic subunits. These studies suggest that the underlying processing events are very similar across all cell types which in turn accounts for the similarities in the post-translational modifications in both nerves and muscle. It should be noted that this type of intracellular trafficking through the organelles in the secretory pathway is not the same as the rapid axoplasmic transport of AChE in nerve cells which occurs after packaging in the trans-Golgi network and movement of the vesicles along microtubules at around 200-400 mm/day.
Evidence for unstable intermediates during AChE biogenesis and assembly
The initial observation that AChE existed as catalytically inactive molecules occurred when the kinetics of appearance of active enzyme molecules was compared to the incorporation of the radioactive amino acid 35 S-methionine into immunoprecipitable protein (Rotundo 1988; Rotundo et al. 1989) . In pulse chase studies, the active AChE continued to increase while the radioactively labeled enzyme decreased with a half-life of about 45 min. Detailed studies showed that the rapidly turning over AChE consisted predominantly of monomers with some dimers, whereas the stable AChE was primarily the assembled tetrameric enzyme. Moreover, the stable enzyme pool was shown to be resistant to endoglycosidase-H indicating that it had left the endoplasmic reticulum and transited the early Golgi compartment. Catalytically inactive AChE has since been documented in vivo in chicken nerves and muscle (Chatel et al. 1993a,b) and human brain (Campanari et al. 2014) .
A second type of unstable form of AChE has been observed that is unstable yet catalytically active, one which rapidly inactivates at elevated temperatures (Eichler and Silman 1995) (Fig. 2) . The rapidly inactivated unstable forms are exclusively monomers and dimers and are also very sensitive to proteases and reducing agents (Rotundo, unpublished observations) . Co-expression of AChE with one of the non-catalytic subunits results in higher order oligomerization and increased stability, as illustrated in Fig. 2 . Most likely these highly unstable catalytically active forms still reside in the endoplasmic reticulum and comprise the as yet unassembled pool of AChE molecules.
Role of the non-catalytic subunits in AChE assembly; PRAD and PRAD-KDEL peptides induce AChE without additional enzyme protein in cultured muscle
Following the cloning and expression of the non-catalytic AChE subunit, the extracellular matrix binding collagenic tail (Krejci et al. 1997) , a detailed mapping of the functional domain of ColQ was carried out . Together, these studies showed that the non-catalytic subunit was essential for higher order assembly and identified a 17 amino acid sequence near the amino terminus highly enriched in prolines that was directly involved in the association of four catalytic subunits to form Fig. 2 Thermal inactivation of mouse AChE at 45°C and stabilization by the PRiMA subunit. (a) COS cells were transfected with a plasmid encoding mouse AChE or co-transfected with a second plasmid encoding the mouse transmembrane anchor PRiMA at a 4 : 1 ratio to induce formation of the membrane-bound tetrameric enzyme. Three days later the cells were extracted and the cell supernatants divided into three equal aliquots; the first remained on ice and the next two were incubated at 45°C for 3 or 15 min, then rapidly cooled on ice. The AChE oligomeric forms were then analyzed by velocity sedimentation on sucrose gradients and assay of enzyme activity using the Ellman assay. G4, AChE tetramers anchored by the PRiMA subunit; G1/G2, AChE monomers and dimers; Agg, an aggregate of dimers that forms from the mouse AChE subunits originally described by Massouli e and colleagues. When heated there is a rapid inactivation of the unstable monomeric and dimeric forms, whereas the PRiMA-induced tetrameric forms is relatively stable at this temperature. (b) The areas under each of the curves illustrated in (a) expressed as percent total at time 0 are plotted versus time to show the kinetics of thermal inactivation of the monomeric and dimeric AChE forms versus the tetrameric AChE assembled with the membrane anchor PRiMA. a tetramer. The peptides involved in this interaction were subsequently co-crystallized to reveal the precise mechanism of association (Dvir et al. 2004) . A similar but not identical oligomerization domain was subsequently mapped on the transmembrane PRiMA subunit as well (Perrier et al. 2002) . This peptide alone is sufficient to induce tetramerization of the AChE catalytic subunits when co-expressed in tissue cultured cells or pre-incubated together in vitro (Bon and Massouli e 1997; Kronman et al. 2000; Chitlaru et al. 2001) .
More recent studies suggest that assembly into higher order oligomeric forms is part of the regulatory mechanism insuring that sufficient AChE molecules are targeted to the synapses. When tissue cultured muscle cells are incubated with a prolinerich attachment domain (PRAD) peptide synthesized with a KDEL endoplasmic reticulum retention sequence on the carboxyl terminus the peptide is taken up and retrogradely transported to the site of AChE assembly (Ruiz et al. 2015) . This in turn results in a large increase in catalytically active AChE, up to 400%, as a consequence of stabilization of the inactive AChE molecules. This is similar to what is observed when the non-catalytic ColQ subunit is over-expressed in skeletal muscle cells (Fig. 3) . Thus, assembly with stabilization by the non-catalytic subunits appears to be an important regulatory step in AChE biogenesis.
Post-translational regulation of AChE assembly by molecular chaperones
The correct folding of newly synthesized exportable proteins in the endoplasmic reticulum requires the assistance of molecular chaperones, proteins that bind to the nascent polypeptide chains, encase the extensive exposed hydrophobic regions and help with the formation of correct disulfide bonds (Braakman et al. 1992; Tatu et al. 1993) . Overexpression of the non-catalytic ColQ subunit or the molecular chaperone protein disulfide isomerase (PDI) results in a large increase in active AChE activity (Fig. 3) . Similar results are seen with other chaperones including Erp72, calnexin and Bip (Ruiz and Rotundo 2009b) . These results suggest that chaperone-mediated folding in the endoplasmic reticulum can be rate limiting and that proteins in the secretory pathway are competing for the attention of the molecular chaperones. Additional studies will be required to sort out the contributions of subunit assembly and chaperones to the overall maturation of active AChE.
The transport and targeting of AChE to specialized domains on the cell surface, targeting AChE forms in polarized cells
Once assembled into higher order oligomeric forms, such as illustrated in Fig. 4 , the AChE molecules must be transported Fig. 3 Over-expression collagen Q tail subunit (ColQ) or protein disulfide isomerase (PDI) enhance active AChE expression and assembly of oligomeric forms in avian skeletal muscle. (a) Overexpression of the non-catalytic collagen tail subunit ColQ, chicken PDI, or both in quail muscle cells in culture. Plasmids expressing each of the proteins were transfected into myoblasts and allowed to fuse and differentiate into myotubes. A12, A8 and A4, collagen-tailed AChE associated with three, two or one tetramer. G1-G4, globular AChE monomers, dimers and tetramers. (b) Total AChE activity expressed after transfection with each or both of the additional proteins. There is an additional synergistic effect of expressing both the non-catalytic subunits together with a molecular chaperone. Each bar is the mean AE SEM of three gradients like those shown in (a). This research was originally published in the Journal of Biological Chemistry. Ruiz CA, Rotundo RL. Dissociation of transcription, translation, and assembly of collagen-tailed acetylcholinesterase in skeletal muscle. J. Biol. Chem. to their sites of function, namely specific types of synapses in the central and peripheral nervous systems including the neuromuscular junction. Like most exportable proteins, the assembled AChE molecules are packaged into transport vesicles through a clathrin-mediated mechanism (Rotundo et al. 1989) . These vesicles then translocate along microtubules and ultimately fuse with the surface plasma membrane where the AChE is either secreted or incorporated into the surface plasma membrane in the case of the PRiMAlinked or glycolipid-anchored forms. The secreted AChE forms consist of globular monomers and dimers, or the large collagen-tailed form that rapidly binds to components of the extracellular matrix such as perlecan and then translocated to sites of nerve-muscle contact (Peng et al. 1999) . While the rapid axoplasmic transport of AChE down motoneurons has been known for many years, the fate of most of the AChE is unclear. Early studies on the localization of cell surface AChE on sympathetic neurons in culture showed that AChE accumulated on the neurites and not the cell bodies (Rotundo and Carbonetto 1987) . These observations suggested that the enzyme was not transported to the cell surface at the cell body. Recent ongoing studies using highly polarized cells in culture now suggest that all AChE forms, secreted, glycolipid anchored and collagen tailed, are all targeted to the apical plasma membrane which in neurons would correspond to the growing axon tip (Rossi et al. unpublished observations) .
Summary and conclusions
While the biogenesis, assembly and trafficking of AChE in the secretory pathway may seem quite ordinary at first glance, the ability to irreversibly inhibit the enzyme at the site of synthesis in the RER with organophosphates, such as diisopropylfluorophosphate, and study the recovery of catalytically active enzyme, has allowed an unprecedented view of the early events in protein folding and maturation in real time. This has not been possible with other proteins typically used as model systems to study protein folding. In addition, the ability to correlate the appearance and fate of radioactively labeled AChE protein with the appearance and fate of the catalytically active enzyme has allowed observations on the behavior of a catalytically inactive pool of AChE molecules. Together these observations tell a novel story of the early events in protein folding and their regulation previously not possible.
It appears that in all systems examined AChE is synthesized initially as a catalytically inactive molecule that then rapidly matures into a catalytically active form. However, this process is incomplete and a large fraction of the inactive enzyme remains in this immature form (Rotundo 1988) , possibly in what many refer to as the molten globule state (Fig. 4) . These molecules have a very short lifespan and are degraded via the endoplasmic reticulum associated degradation with a half-life of about 45 min. Those that do mature to the point of becoming catalytically active still remain in an unstable state, even though they may assemble into functional dimers, as they are thermodynamically unstable and rapidly unfold and lose activity when heated to 45°C (Fig. 2) . They are also unstable when exposed to dithiothreitol or proteases (Rotundo, unpublished observations) . Thus, they are intermediate between the newly synthesized catalytically inactive enzyme and the fully mature and stable oligomeric forms. These unstable forms appear to be entirely in the endoglycosidase-H sensitive state suggesting that they still reside in the endoplasmic reticulum.
What then regulates the maturation and stabilization of the newly synthesized AChE? The most likely possibility is the direct interactions with the non-catalytic subunits, ColQ and PRiMA, or as yet some other unidentified PRAD-like peptide as has been described for butyrylcholinesterase (Biberoglu et al. 2013; Schopfer and Lockridge 2016) . These could even be proteolytic fragments of the ColQ subunit generated Fig. 4 Model illustrating the steps involved in assembling the higher order AChE oligomeric forms. Nascent AChE polypeptides are assisted in their folding through the aid of chaperones leading to the formation of partially folded unstable intermediates, some with catalytic activity. These are then further assembled into higher order forms such as the collagentailed form or the PRiMA-linked tetramers, or the glycolipid-anchored AChE dimers. MG, molten globule; G1 globular monomer; G2, globular dimer; G4, globular tetramer; NCS, non-catalytic subunit; ECM, extracellular matrix.
in vivo since the non-catalytic subunit appears to be synthesized in vast excess over the amount used to assemble the 16-20S collagen-tailed AChE form (Ruiz and Rotundo 2009a,b) . However, an additional potential regulatory event is the chaperone-mediated folding steps themselves in the endoplasmic reticulum (Ruiz and Rotundo 2009b) . With the over-expression of individual chaperones comes, a parallel increase in catalytically active and fully assembled AChE expression and this is synergistically enhanced by the coexpression of non-catalytic subunits. These molecular chaperones can be rate limiting under certain circumstances and act by increasing the folding of both the AChE catalytic and non-catalytic subunits. These studies also suggest a therapeutic application of the PRAD peptides since a synthetic PRAD-KDEL peptide can be taken up by cells where it rescues the inactive AChE from degradation (Ruiz et al. 2015) . This ability to increase AChE could be useful in the treatment of patients suffering from nerve agent or pesticide exposure. Clearly, there is still much to be learned about the biogenesis and assembly of AChE in eukaryotic cells.
